SBIC Capital Infusion Act of 2020
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
SBIC Capital Infusion Act of 2020
This bill provides economic assistance to small businesses affected by COVID-19 (i.e., coronavirus disease 2019), and it reestablishes the New Markets Venture Capital Program.
Specifically, the bill provides additional leverage for small business investment companies (SBICs) by requiring the Small Business Administration (SBA), when calculating the maximum amount of outstanding leverage made available to SBICs, to exclude a certain amount of outstanding leverage to small businesses affected by COVID-19. Any excluded amounts must be used solely for working capital purposes.
The bill also reestablishes the New Markets Venture Capital Program, through which the SBA, in partnership with investment companies, encourages developmental venture capital investment in small businesses located in low-income areas.
Referred to the House Committee on Small Business.
- Introduced in House Formatted Text PDF Formatted XML
Cite this page
U.S. Congress. (2026). H.R. 6342: SBIC Capital Infusion Act of 2020. 116th Congress. Open America. https://openamerica.io/bill/116-HR-6342/
"H.R. 6342: SBIC Capital Infusion Act of 2020." 116th Congress, 2026, Open America, https://openamerica.io/bill/116-HR-6342/.
H.R. 6342, 116th Cong. (2026), https://openamerica.io/bill/116-HR-6342/.
[H.R. 6342: SBIC Capital Infusion Act of 2020](https://openamerica.io/bill/116-HR-6342/)